Author

Andrea Stutz

Fraunhofer Institute for Toxicology and Experimental MedicineORCID 0000-0002-8702-7278Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:human· 1

Frequent Co-Authors

Boris KubuschokiD· 1 shared Catherine BotteroniD· 1 shared Celine Baron· 1 shared Christian WernoiD· 1 shared Christoph A. KleiniD· 1 shared Dagmar Halbritter· 1 shared Dennis Christoph HarreriD· 1 shared Durdam DasiD· 1 shared

Activity by Year

2026-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Boris KubuschokORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Cancer BiologybioRxivPreprintFeb 9, 2026

Ex vivo drug testing in metastatic biopsies reveals patient-specific vulnerabilities to cancer targeting and immune activating drugs

Lukas Wöhrl, Durdam Das, Kathrin Weidele…·Christian Werno

This study introduces PEDRA, an ex vivo drug response assay that identifies patient-specific treatment options in metastatic biopsies, outperforming prior therapies and informing immune responses.

DOI 10.64898/2026.02.06.704037

humanexperimental assay

𝕏 PostBluesky